| Literature DB >> 29638208 |
Peyman Bakhshaei1, Mohammad Hossein Kazemi1, Maryam Golara1, Sara Abdolmaleki1, Roya Khosravi-Eghbal1, Jalal Khoshnoodi1, Mohammad Ali Judaki1, Vahid Salimi2, Masoumeh Douraghi3, Mahmood Jeddi-Tehrani4, Fazel Shokri1,4.
Abstract
Vaccination with whole-cell or acellular (Ac) vaccines has been very effective for the control of pertussis. The immune response to Ac vaccines has been generally associated with a shift toward the Th2 profile. In the present study, overlapping recombinant fragments of filamentous hemagglutinin (FHA) and pertactin (PRN) were produced in Escherichia coli. BALB/c mice were immunized with recombinant FHA and PRN together with the native pertussis toxin and alum or CpG as adjuvant. Immunized mice were subsequently aerosol challenged with Bordetella pertussis. Bacterial growth was assessed in bronchoalveolar lavage samples and the levels of cytokines were quantitated in supernatants of stimulated splenocytes by enzyme-linked immunosorbent assay. Our results demonstrated that both PRN and FHA antigens were able to induce IFN-γ, IL-4, and to some extent IL-17 cytokines in challenged mice. The level of IFN-γ was higher in response to CpG formulated antigens. These findings indicate immunoprotective efficacy of our recombinant FHA and PRN antigens in mice.Entities:
Keywords: Bordetella pertussis; acellular pertussis vaccine; cellular immunity; filamentous hemagglutinin; pertactin; pertussis infection
Mesh:
Substances:
Year: 2018 PMID: 29638208 DOI: 10.1089/jir.2017.0060
Source DB: PubMed Journal: J Interferon Cytokine Res ISSN: 1079-9907 Impact factor: 2.607